Genome News and Research

RSS

COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron

A team of scientists from the United States has recently demonstrated that current coronavirus disease 2019 (COVID-19) vaccines induce robust spike-specific T cell responses against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

1 Feb 2022

Liver hormone suppresses alcohol consumption in primates, study shows

A hormone produced by the liver called fibroblast growth factor 21 (FGF21) suppresses alcohol consumption in primates, finds a study published February 1 in the journal Cell Metabolism.

1 Feb 2022

Developing post-vaccination SARS-CoV-2 standard reference sera

A new study reports the generation of reference sera reagents that were obtained from subjects vaccinated with one of four COVID-19 vaccines.

1 Feb 2022

SARS-CoV-2 entry at the cell surface facilitated by trypsin

Exogenous trypsin treatment boosts SARS-CoV-2 infection in Vero E6 cells and promotes viral multiplication in cultured cells.

1 Feb 2022

Families of Black patients found to have greater risk for dilated cardiomyopathy

Black patients diagnosed with dilated cardiomyopathy (DCM) of unknown cause are more likely to have family members at risk of developing the heart muscle disease than families of white patients, according to results of a multi-site study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine.

1 Feb 2022

Impact of using AI to generate primers for detection of SARS-CoV-2 Omicron variant

In a new study, researchers designed artificial intelligence (AI)-based primers for the SARS-CoV-2 Omicron variant.

1 Feb 2022

SARS-CoV-2 protein NSP2 found to impair microRNA-induced gene silencing in human cells

In a new study, a team of researchers used co-immunoprecipitation and in vitro interaction assays to identify the molecular basis of interaction of SARS-CoV-2 non-structural protein 2 with eIF4E-homologous protein (4EHP)-GRB10-interacting glycine-tyrosine-phenylalanine domain protein 2 complex, involved in microRNA-mediated gene silencing in human cells.

1 Feb 2022

Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesis

Biotechnology company Ingenza is excited to report the successful conclusion to its recent six-month project with Johnson Matthey.

1 Feb 2022

Researchers develop new technique to open the blood-brain barrier in lab animals

University of Maryland School of Medicine researchers developed a technique in laboratory animals to consistently and reproducibly open the blood-brain barrier.

31 Jan 2022

Fusion oncogenes associated with more invasive pediatric thyroid cancers, study says

Fusion oncogenes, such as RET- and NTRK-gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest risk of metastases and a lower likelihood of achieving remission one year after initial therapy, according to a new study by researchers at Children's Hospital of Philadelphia (CHOP).

31 Jan 2022

New study on mutation origination fundamentally challenges neo-Darwinism

A new study by a team of researchers from Israel and Ghana has brought the first evidence of nonrandom mutation in human genes, challenging a core assumption at the heart of evolutionary theory by showing a long-term directional mutational response to environmental pressure.

31 Jan 2022

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Researchers determined the analytical sensitivity of a CE-marked fast antigen with the SARS-CoV-2 Omicron, Delta, Alpha, and Gamma variants.

31 Jan 2022

Evaluating clinical outcomes and viral loads of SARS-CoV-2 Delta and Omicron infections

The current study showed a marked decrease in disease severity with Omicron compared to the Delta variant.

31 Jan 2022

A substrate envelope approach to examine drug resistance potential of SARS-CoV-2 Mpro

A team of scientists from the United States has recently defined the substrate envelop of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is currently available on the bioRxiv* preprint server while awaiting peer review.

31 Jan 2022

Immunity based upon “mild" Omicron infection is weak for Omicron reinfection

Researchers evaluate antibody responses in vaccinated individuals who subsequently developed Delta and Omicron SARS-CoV-2 breakthrough infections.

30 Jan 2022

Scientists evaluate zoonotic potential of NeoCoV, a coronavirus related to MERS-CoV

Researchers identify ACE2 as the functional receptor of the two close relatives of MERS-CoV, NeoCoV and PDF-2180-CoV, in bats.

30 Jan 2022

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

The Damon Runyon Cancer Research Foundation has announced its newest cohort of Damon Runyon Fellows, 13 outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators.

29 Jan 2022

Parasite present in seawater will help to explain how multicellularity developed in animals

Researchers from the UPV/EHU-University of the Basque Country and CEFAS have discovered a parasite present in seawater and which belongs to a primitive lineage; they have named it Txikispora philomaios.

29 Jan 2022

Study identifies high-priority genes associated with uterine cancer that could be potential drug targets

No single gene causes uterine cancer, the fourth most common cancer among women, which is on the rise in the U.S.

28 Jan 2022

Oligodendrocytes may have a different role in the development of multiple sclerosis, study finds

An international team of researchers led by Karolinska Institutet in Sweden have discovered that a cell type in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) than previously thought.

28 Jan 2022

Genome News and Research

COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron

Liver hormone suppresses alcohol consumption in primates, study shows

Developing post-vaccination SARS-CoV-2 standard reference sera

SARS-CoV-2 entry at the cell surface facilitated by trypsin

Families of Black patients found to have greater risk for dilated cardiomyopathy

Impact of using AI to generate primers for detection of SARS-CoV-2 Omicron variant

SARS-CoV-2 protein NSP2 found to impair microRNA-induced gene silencing in human cells

Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesis

Researchers develop new technique to open the blood-brain barrier in lab animals

Fusion oncogenes associated with more invasive pediatric thyroid cancers, study says

New study on mutation origination fundamentally challenges neo-Darwinism

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Evaluating clinical outcomes and viral loads of SARS-CoV-2 Delta and Omicron infections

A substrate envelope approach to examine drug resistance potential of SARS-CoV-2 Mpro

Immunity based upon “mild" Omicron infection is weak for Omicron reinfection

Scientists evaluate zoonotic potential of NeoCoV, a coronavirus related to MERS-CoV

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

Parasite present in seawater will help to explain how multicellularity developed in animals

Study identifies high-priority genes associated with uterine cancer that could be potential drug targets

Oligodendrocytes may have a different role in the development of multiple sclerosis, study finds

Genetics & Genomics - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News